Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 38,720 shares at $40.95 ($1.6M) on 2025-09-11, disclosed to the SEC on 2025-09-11.
Scheduled sale ($1.6M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.33 | 14,080 | $568K | 36.2% |
| 2 | $40.33 | 14,080 | $568K | 36.2% |
| 3 | $41.29 | 3,520 | $145K | 9.3% |
| 4 | $41.29 | 3,520 | $145K | 9.3% |
| 5 | $40.95 | 3,520 | $144K | 9.2% |
| Total | $40.56 avg | 38,720 |
| $1.6M |
| 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |